Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Urologia. 2022 Aug;89(3):354-357. doi: 10.1177/03915603211034943. Epub 2021 Jul 29.
Systematic regional lymph node dissection (LND) combined with radical nephroureterectomy (RNU) has been reported to improve the outcomes of upper tract urothelial carcinoma (UTUC) patients. The objective of the present study was to assess the prognostic outcomes of UTUC patients undergoing systematic regional LND combined with RNU.
We conducted a retrospective evaluation of prognostic outcomes of 68 consecutive UTUC patients treated with RUN and systematic regional LND.
The median durations of recurrence-free survival (RFS) and overall survival (OS) were 45 and 166 months, respectively. Univariate analyses of several parameters showed that despite the lack of a significant predictor for RFS, the presence of lymph node metastasis correlated with poor OS.
These results suggest that comparatively favorable outcomes are achievable in UTUC patients by RNU and systematic regional LND; however, special attention is needed for patients with nodal involvement even after systematic regional LND due to the adverse impact of this factor on OS.
系统区域性淋巴结清扫(LND)联合根治性肾输尿管切除术(RNU)已被报道可改善上尿路尿路上皮癌(UTUC)患者的预后。本研究旨在评估接受系统区域性 LND 联合 RNU 的 UTUC 患者的预后结果。
我们对 68 例接受 RUN 和系统区域性 LND 治疗的 UTUC 患者的预后结果进行了回顾性评估。
无复发生存期(RFS)和总生存期(OS)的中位数分别为 45 个月和 166 个月。对多个参数的单因素分析表明,尽管 RFS 没有明显的预测因素,但淋巴结转移的存在与较差的 OS 相关。
这些结果表明,RNU 和系统区域性 LND 可使 UTUC 患者获得相对较好的预后;然而,由于该因素对 OS 的不利影响,即使在进行了系统区域性 LND 后,淋巴结受累的患者仍需特别关注。